Biosen-Driven Growth-Coupled Evolution of Epimerases Improves D-Allulose Biosynthesis

Enzyme performance is the bottleneck

D-Allulose formulators know the frustration. The epimerase that converts D-fructose to D-allulose often lacks enough activity or thermal stability for industrial conditions. You can add more enzyme, but that drives up cost. You can run longer, but that cuts productivity. The better path is a better enzyme.

A research team recently published work in Advanced Science showing how they used a D-allulose-dependent biosensor to evolve an epimerase under growth-coupled selective pressure. They called the starting enzyme ADAE. After directed evolution, the best mutant, M42, showed 6.28-fold higher catalytic activity and a 2.5-fold longer half-life at 60°C. In a 3-hour reaction from D-fructose, it hit 32.2% conversion to D-allulose.

Why KEases are hard to engineer

Ketose 3-epimerases (KEases) interconvert D-fructose and D-allulose. They are the biocatalytic workhorses behind allulose production. But conventional screening methods rely on colorimetric assays or chromatographic runs. Those methods are slow, low-throughput, and often miss subtle improvements in thermostability or catalytic efficiency.

The problem is not finding a mutant. The problem is finding the rare mutant among thousands. You need a selection system that rewards the enzyme you actually want.

What the study did

The researchers built a growth-coupled in vivo screening platform. The core is a D-allulose-dependent biosensor, which they call Biosen. When an engineered cell produces D-allulose from D-fructose, the biosensor activates a growth-linked reporter. More allulose means better growth.

That turns enzyme evolution into a survival contest. Variants with improved activity convert more substrate, generate a stronger signal, and grow faster. This removes the need to screen individual colonies by hand. Evolution pressure does the sorting.

The team used this platform on ADAE, a D-allulose 3-epimerase. They generated mutant libraries and let the growth-coupled sensor enrich the best performers. Then they characterized the top hit, M42.

Key findings

The data separates M42 from the parent enzyme on two practical fronts.

Metric	Reported result
Catalytic activity vs. parent ADAE	6.28-fold higher
Half-life at 60°C	2.5-fold longer
D-allulose conversion from D-fructose in 3 h	32.2%

Those numbers matter in an industrial setting. Activity determines enzyme loading and residence time. Thermal stability determines how long the enzyme survives at reaction temperatures. A 2.5-fold longer half-life at 60°C can mean a serious reduction in enzyme consumption.

The 32.2% conversion is also notable. Allulose production from fructose is thermodynamically limited, and many reported systems stall in the 20-30% range. M42 reached 32.2% in three hours without the study needing to optimize reaction conditions.

What this means for manufacturers

For buyers and formulators, this is not just an academic exercise. Enzyme suppliers often sell KEases with generic performance claims. The study offers a screening approach that can push those enzymes past current limits.

Growth-coupled biosensor screening is faster than conventional directed evolution. That could shorten the development cycle for next-generation allulose enzymes. For manufacturers, that means potential access to biocatalysts with higher space-time yield and lower enzyme cost per kilogram of allulose.

It also signals that allulose enzyme innovation is shifting from random mutagenesis to smarter, growth-linked selection. When you evaluate enzyme suppliers, ask how they engineer their catalysts. Suppliers who use high-throughput in vivo selection systems may deliver better-performing enzymes in the future.

FAQ

What is a growth-coupled biosensor screen?

It links the production of D-allulose to cell survival or growth. A biosensor detects allulose and activates a growth signal. Cells carrying better enzyme variants produce more allulose and grow faster, so they take over the culture. This enriches the best mutants without manual screening.

Is the M42 mutant ready for commercial allulose production?

The paper does not address scale-up or industrial formulation. It demonstrates a powerful screening platform and a mutant with meaningful performance gains in lab-scale reactions. Refining reaction conditions, enzyme dosage, and immobilization would be the next steps.

Does this platform only work for D-allulose epimerases?

The principle is general, but this study specifically uses a D-allulose-dependent biosensor. Adapting the approach to other rare sugars would require a biosensor for the target product. That is still a major constraint.

A smarter route to better allulose enzymes

This work gives formulators a clear reason to watch enzyme R&D more closely. The M42 mutant shows what growth-coupled evolution can achieve: more active, more stable, and productive enough to convert a third of fructose to allulose in three hours. The platform itself may be the bigger story. Directed evolution is no longer just random mutations and slow assays. When the cell rewards the right enzyme, the best catalyst finds itself.